|
Dataset ID |
Tissue / Organ |
Experiment type |
Sample |
Cell type |
Marker class |
Evidence |
|
PRJNA415636 (heart, blood) |
heart, blood |
baseline |
adult, Zebrabow M, heart and blood |
Cardiomyocytes (cluster: 8)
|
marker
|
DOI:10.1038/nbt.4124
|
|
GSE126647 (control) |
embryo |
baseline |
1.17dpf, control nkx2.5:ZsYellow+ cells |
Differentiated art.CMs (cluster: 2)
|
potential marker
|
NA
|
|
GSE126647 (Pbx4-depleted) |
embryo |
growth |
1.17dpf, Pbx4-depleted nkx2.5:ZsYellow+ cells |
Differentiated art.ventricle (cluster: 4)
|
potential marker
|
NA
|
|
PRJNA706197 (18hpf) |
embryo |
baseline |
18hpf, FACS sorted sox10:nEOS cells |
Cardiac mesoderm (cluster: 5)
|
potential marker
|
NA
|
|
PRJNA564810 (1dpf) |
embryo |
baseline |
1dpf, a single-cell transcriptome atlas for zebrafish development |
Heart primordium (cluster: 30)
|
potential marker
|
NA
|
|
PRJNA608912 (wt_unjuried) |
heart |
baseline |
5mpf, wild type, uninjured |
|
|
|
|
PRJNA608912 (wt_7dpi) |
heart |
regeneration |
5mpf, wild type, 7 days post injury |
|
|
|
|
PRJNA608912 (kit_2dpi) |
heart |
regeneration |
5mpf, kit mutant, 2 days post injury |
|
|
|
|
PRJNA608912 (kit_7dpi) |
heart |
regeneration |
5mpf, kit mutant, 7 days post injury |
|
|
|
|
PRJNA608912 (kit_14dpi) |
heart |
regeneration |
5mpf, kit mutant, 14 days post injury |
|
|
|
|
GSE144944 (fgfr3 +|+) |
cranial vault |
baseline |
1mpf, fgfr3 +/+ |
|
|
|
|
GSE144944 (fgfr3 -|-) |
cranial vault |
growth |
1mpf, fgfr3 -/- |
|
|
|
|
GSE158849 (unlabeled) |
embryo |
baseline |
6hpf, WT, 4sUTP injected (unlabeled) |
|
|
|
|
PRJNA706197 (24hpf) |
embryo |
baseline |
24hpf, FACS sorted sox10:nEOS cells |
|
|
|
|
PRJNA564810 (2dpf) |
embryo |
baseline |
2dpf, a single-cell transcriptome atlas for zebrafish development |
|
|
|
|
GSE168695 (5dpf) |
embryo |
baseline |
5dpf, GFP+ cells isolated from 5 dpf cldnb:lyn-EGFP embryos |
|
|
|
|
PRJNA564810 (5dpf) |
embryo |
baseline |
5dpf, a single-cell transcriptome atlas for zebrafish development |
|
|
|
|
GSE158142 (24hpf) |
head |
baseline |
24hpf, untreatment |
|
|
|
|
GSE158142 (16hpf) |
head |
baseline |
16hpf, 14 somites, untreatment |
|
|
|
|
GSE158142 (1.5dpf) |
head |
baseline |
1.5dpf, untreatment |
|
|
|
|
GSE158142 (18hpf) |
head |
baseline |
18hpf, 18 somites, untreatment |
|
|
|
|
GSE158142 (3dpf) |
head |
baseline |
3dpf, untreatment |
|
|
|
|
GSE158142 (20hpf) |
head |
baseline |
20hpf, 21-22 somites, untreatment |
|
|
|
|
PRJNA608912 (wt_14dpi) |
heart |
regeneration |
5mpf, wild type, 14 days post injury |
|
|
|
|
PRJNA608912 (kit_uninjuried) |
heart |
regeneration |
5mpf, kit mutant, uninjured |
|
|
|
|
PRJNA608912 (wt_2dpi) |
heart |
regeneration |
5mpf, wild type, 2 days post injury |
|
|
|
|
GSE150498 (wildtype, 2X DSS+BZA) |
intestine |
disease |
6dpf, wildtype, 2X DSS+BZA |
|
|
|
|
GSE150498 (wildtype, untreated) |
intestine |
baseline |
6dpf, wildtype, untreated |
|
|
|
|
GSE150498 (wildtype, 1X DSS) |
intestine |
disease |
6dpf, wildtype, 1X DSS |
|
|
|
|
GSE150498 (nod2-|-, 1X DSS) |
intestine |
disease |
6dpf, nod2-/-, 1X DSS |
|
|
|
|
PRJNA605021 (supporting cells) |
neuromast |
baseline |
7dpf, posterior lateral-line neuromast cells were isolated from the dissociated trunks of Tg[Et(krt4:EGFP)sqgw57A] transgenic zebrafish larvae |
|
|
|
|
PRJNA668529 (3d) |
olfactory rosette |
disease |
3mpf, intranasal 100ng r-Spike 3 days |
|
|
|
|
PRJNA668529 (3h) |
olfactory rosette |
disease |
3mpf, intranasal 100ng r-Spike 3 hours |
|
|
|
|
PRJNA668529 (control) |
olfactory rosette |
baseline |
3mpf, intranasal PBS |
|
|
|
|
PRJNA415636 (primary pancreatic islet) |
primary pancreatic islet |
baseline |
adult, Zebrabow M, primary pancreatic islet |
|
|
|
|
GSE175929 (5mpf) |
retina |
baseline |
5mpf, GFP-positive cells collected from two transgenic zebrafish, Tg(rho:EGFP)ja2Tg and Tg(gnat2:EGFP)ja23Tg |
|
|
|
|
PRJNA551501 (2mpf) |
thyroid gland |
baseline |
2mpf, Tg(tg:mVenus-T2A-NTR) |
|
|
|
|
PRJNA551501 (8mpf) |
thyroid gland |
baseline |
8mpf, Tg(tg:mVenus-T2A-NTR) |
|
|
|
|
PRJNA641144 (P_PRO) |
tumor |
disease |
adult, ZMEL1-PRO cells in vivo primary tumors |
|
|
|
|
GSE158099 (WT) |
whole body |
baseline |
2.5dpf, cd41:GFPlow-WT |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
16dpf, cd41:GFPlow-runx1-/- |
|
|
|
|
GSE158099 (WT) |
whole body |
baseline |
6dpf, cd41:GFPlow-WT |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
16dpf, cd41:GFPlow-runx1-/- |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
6dpf, cd41:GFPlow-runx1-/- |
|
|
|
|
GSE176129 (pdgfrb-positive) |
whole body |
baseline |
5dpf, FACS-isolated pdgfrb-positive cells |
|
|
|
|
GSE158099 (WT) |
whole body |
baseline |
16dpf, cd41:GFPlow-WT |
|
|
|